Clinical Trials Browser

Phase 1/2 × Chromosome 5q Deletion Syndrome × Clear all

NCT00839982 2017-07-11

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Phase 1/2 Completed

35 enrolled 11 charts

Other hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Leukemia, Myeloid, Acute